US2019167742A1PendingUtilityA1

Therapy for promoting cell growth

59
Assignee: MOLEAC PTE LTDPriority: Mar 27, 2009Filed: Jan 8, 2019Published: Jun 6, 2019
Est. expiryMar 27, 2029(~2.7 yrs left)· nominal 20-yr term from priority
A61P 43/00A61P 9/10A61P 9/00A61P 25/02A61P 25/14A61P 25/08A61P 25/00A61P 25/28A61P 25/24A61P 25/06A61P 21/00A61P 21/02A61K 36/65A61K 36/736A61K 45/06A61K 38/00A61K 36/69A61K 36/286A61K 36/481A61K 36/537A61K 36/232A61K 35/62A61K 36/882A61K 36/236
59
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

There is disclosed the use of a composition for promoting neuronal growth of neurons in tissues of the central or peripheral nervous system. There is also disclosed a method for inducing proliferation or differentiation of neuronal cells.

Claims

exact text as granted — not AI-modified
1 - 73 . (canceled) 
     
     
         74 . A composition consisting of the following four herbal components:
 i) Radix Polygalae;   ii) Radix Astragali;   iii) Rhizoma Chuanxiong; and   iv) Radix Angelicae sinensis,   wherein each herbal component is present in the composition as an unprocessed or crushed herb or as a purified extract.   
     
     
         75 . The composition according to  claim 74 , wherein each herbal component is present in the composition as a purified extract. 
     
     
         76 . The composition according to  claim 74 , wherein Radix Polygalae, Rhizoma Chuanxiong, Radix Angelicae sinensis, and Radix Astragali are present in the composition in a ratio of about 1:1:1:5 by weight, respectively. 
     
     
         77 . The composition according to  claim 75 , wherein Radix Polygalae, Rhizoma Chuanxiong, Radix Angelicae sinensis, and Radix Astragali are present in the composition in a ratio of about 1:1:1:5 by weight, respectively. 
     
     
         78 . The composition according to  claim 74 , wherein said composition is a pharmaceutical composition further comprising a pharmaceutically acceptable additive, carrier or diluent. 
     
     
         79 . The composition according to  claim 75 , wherein said composition is a pharmaceutical composition further comprising a pharmaceutically acceptable additive, carrier or diluent. 
     
     
         80 . The composition according to  claim 76 , wherein said composition is a pharmaceutical composition further comprising a pharmaceutically acceptable additive, carrier or diluent. 
     
     
         81 . The composition according to  claim 77 , wherein said composition is a pharmaceutical composition further comprising a pharmaceutically acceptable additive, carrier or diluent. 
     
     
         82 . The composition according to  claim 78 , formulated for oral delivery. 
     
     
         83 . The composition according to  claim 79 , formulated for oral delivery. 
     
     
         84 . The composition according to  claim 80 , formulated for oral delivery. 
     
     
         85 . The composition according to  claim 81 , formulated for oral delivery. 
     
     
         86 . The composition according to  claim 78 , formulated as one or more tablets or capsules. 
     
     
         87 . The composition according to  claim 79 , formulated as one or more tablets or capsules. 
     
     
         88 . The composition according to  claim 80 , formulated as one or more tablets or capsules. 
     
     
         89 . The composition according to  claim 81 , formulated as one or more tablets or capsules. 
     
     
         90 . The composition according to  claim 78 , administered to a subject to diminish the effects of a stroke and/or a neurodegenerative disorder, wherein said composition is administered in combination with one or more supplemental agents. 
     
     
         91 . The composition according to  claim 79 , administered to a subject to diminish the effects of a stroke and/or a neurodegenerative disorder, wherein said composition is administered in combination with one or more supplemental agents. 
     
     
         92 . The composition according to  claim 80 , administered to a subject to diminish the effects of a stroke and/or a neurodegenerative disorder, wherein said composition is administered in combination with one or more supplemental agents. 
     
     
         93 . The composition according to  claim 81 , administered to a subject to diminish the effects of a stroke and/or a neurodegenerative disorder, wherein said composition is administered in combination with one or more supplemental agents. 
     
     
         94 . The composition according to  claim 78 , administered to a subject to diminish the effects of a stroke and/or a neurodegenerative disorder, wherein said composition is administered in combination with one or more vitamins, mineral supplements, herbal supplements, fish oils and/or Western medicines. 
     
     
         95 . The composition according to  claim 79 , administered to a subject to diminish the effects of a stroke and/or a neurodegenerative disorder, wherein said composition is administered in combination with one or more vitamins, mineral supplements, herbal supplements, fish oils and/or Western medicines. 
     
     
         96 . The composition according to  claim 80 , administered to a subject to diminish the effects of a stroke and/or a neurodegenerative disorder, wherein said composition is administered in combination with one or more vitamins, mineral supplements, herbal supplements, fish oils and/or Western medicines. 
     
     
         97 . The composition according to  claim 81 , administered to a subject to diminish the effects of a stroke and/or a neurodegenerative disorder, wherein said composition is administered in combination with one or more vitamins, mineral supplements, herbal supplements, fish oils and/or Western medicines.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.